B Seifert
Lesions with unclear malignant potential (B3) after minimally invasive breast biopsy: evaluation of vacuum biopsies performed in Switzerland and recommended further management
Saladin C, Kubik-Huch R, Stadlmann S, Rageth C, Rageth L, Seifert B, Öhlschlegel C, Kampmann G, Haueisen H. Lesions with unclear malignant potential (B3) after minimally invasive breast biopsy: evaluation of vacuum biopsies performed in Switzerland and recommended further management. Acta Radiol 2015; 57:815-21.
08.11.2015Lesions with unclear malignant potential (B3) after minimally invasive breast biopsy: evaluation of vacuum biopsies performed in Switzerland and recommended further management
08.11.2015Acta Radiol 2015; 57:815-21
Saladin Camilla, Kubik-Huch Rahel A, Stadlmann S, Rageth Christoph, Rageth Luzi, Seifert B, Öhlschlegel Christian, Kampmann Gert, Haueisen Harald
Primary cutaneous lymphoma: two-decade comparison in a population of 263 cases from a Swiss tertiary referral centre
Jenni D, Karpova M, Seifert B, Golling P, Cozzio A, Kempf W, French L, Dummer R. Primary cutaneous lymphoma: two-decade comparison in a population of 263 cases from a Swiss tertiary referral centre. Br J Dermatol 2011; 164:1071-7.
01.05.2011Primary cutaneous lymphoma: two-decade comparison in a population of 263 cases from a Swiss tertiary referral centre
01.05.2011Br J Dermatol 2011; 164:1071-7
Jenni D, Karpova M B, Seifert B, Golling Ph, Cozzio Antonio, Kempf W, French L E, Dummer R
First-line temozolomide combined with bevacizumab in metastatic melanoma: a multicentre phase II trial (SAKK 50/07)
von Moos R, Dummer R, Schönewolf N, Mamot C, Mjhic-Probst D, Schraml P, Moch H, Schläppi M, Cathomas R, Michielin O, Ochsenbein A, Gillessen S, Goldinger S, Simcock M, Seifert B, on behaalf of the Swiss Group for Clinical Cancer Research (SAKK). First-line temozolomide combined with bevacizumab in metastatic melanoma: a multicentre phase II trial (SAKK 50/07). Ann Oncol 2011; 23:531-6.
28.04.2011First-line temozolomide combined with bevacizumab in metastatic melanoma: a multicentre phase II trial (SAKK 50/07)
28.04.2011Ann Oncol 2011; 23:531-6
von Moos R, Dummer R, Schönewolf N, Mamot C, Mjhic-Probst D, Schraml P H, Moch H, Schläppi M, Cathomas R, Michielin O, Ochsenbein A, Gillessen S, Goldinger S M, Simcock M, Seifert B, on behaalf of the Swiss Group for Clinical Cancer Research (SAKK)
Fetus and uteroplacental unit: fast MR imaging with three-dimensional reconstruction and volumetry--feasibility study
Kubik-Huch R, Wildermuth S, Cettuzzi L, Rake A, Seifert B, Chaoui R, Marincek B. Fetus and uteroplacental unit: fast MR imaging with three-dimensional reconstruction and volumetry--feasibility study. Radiology 2001; 219:567-73.
01.05.2001Fetus and uteroplacental unit: fast MR imaging with three-dimensional reconstruction and volumetry--feasibility study
01.05.2001Radiology 2001; 219:567-73
Kubik-Huch R A, Wildermuth Simon, Cettuzzi L, Rake A, Seifert B, Chaoui R, Marincek B